The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the American Psychiatric Association (APA), around one out of every twenty-four patients in 2018 had severe mental illnesses, including major psychotic disorders.
The rising incidence of psychiatric disorders places a significant pressure on healthcare system. As a result, the government is focused on raising awareness about disorders and the efficacy of drugs used to treat them. As a result, there is a huge demand for highly effective and safe drugs to treat people with psychotic disorders all over the globe. Furthermore, the firms are concentrating on the identification of innovative antipsychotic injectable drugs, that reduce the need to monitor the patient's drug consumption. Schizophrenia and psychotic disorders have a high incidence, which is driving the global antipsychotic drug market. Additional reasons driving the market growth for antipsychotic drugs include increased drug abuse, over-prescription of drugs, and addiction to antipsychotic drugs.
In March 2020, Dr. Reddy's Laboratories announced the launch of Ziprasidone Mesylate for injection, 20 mg (base)/ml single-dose vials, in the United States. Ziprasidone Mesylate for injection is the generic therapeutic equivalent to Pfizer's Geodon injection.
In January 2020, The US Food and Medication Administration (FDA) had approved Alkermes' experimental antipsychotic drug candidate ALKS 3831 (olanzapine/samidorphan), which is used to treat schizophrenia and bipolar I disorder.
Market Coverage
o By Type
o By Application
o By distribution
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Market Segmentation
Global Neuroleptic market is segmented by Type
o Risperidone
o Olanzapine
o Quetiapine
o Ziprasidone
o Aripiprazole
o Paliperidone
o Lurasidone
Global Neuroleptic market is segmented by Application
o Bipolar I Disorder
o Schizophrenia
o Schizoaffective Disorder
o Major Depressive Disorder (MDD)
Global Neuroleptic market is segmented by Distribution
o Hospital Pharmacy
o Retail Pharmacy
o Drug Store
o E-commerce
Global Neuroleptic market is segmented by Region
North America
Europe
Asia-Pacific
Rest of the World
REQUEST FOR TABLE
OF CONTENT